Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity ; volume:9 ; number:1 ; day:19 ; month:12 ; year:2012 ; pages:1-16 ; date:12.2012
Journal of neuroinflammation ; 9, Heft 1 (19.12.2012), 1-16, 12.2012
- Urheber
-
Harati, Rania
- Beteiligte Personen und Organisationen
-
Villégier, Anne-Sophie
Banks, William A.
Mabondzo, Aloise
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-9-273
- URN
-
urn:nbn:de:1111-2016032331432
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Harati, Rania
- Villégier, Anne-Sophie
- Banks, William A.
- Mabondzo, Aloise
- SpringerLink (Online service)
Ähnliche Objekte (12)
Decreased blood-brain barrier P-glycoprotein function with aging
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
In silico the blood-brain barrier permeation and P-glycoprotein interaction modeling of various chemical compounds and cyclodextrin-formulated drugs
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model
Decreased blood-brain barrier P-glycoprotein function with aging
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
In silico the blood-brain barrier permeation and P-glycoprotein interaction modeling of various chemical compounds and cyclodextrin-formulated drugs
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model
Decreased blood-brain barrier P-glycoprotein function with aging
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
In silico the blood-brain barrier permeation and P-glycoprotein interaction modeling of various chemical compounds and cyclodextrin-formulated drugs
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein